Company News

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

Pac Roots Cannabis Corp. (CSE: PACR) (“PacRoots” or the “Company”), announces the closing of its previously announced non-brokered private placement (see press release dated January 25, 2021).

Aggregate gross proceeds of $1,340,685.90 were raised through the issuance of 7,448,255 units (each a “Unit”). Each Unit consists of one common shares and one share purchase warrant. Each warrant is exercisable at a price of $0.30 per share until February 23, 2024.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced an article covering FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF).

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6612/75312_196f8c2f4448b9a4_001.jpg

Keep reading... Show less

Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has published a new research report on Lobe Sciences Ltd. (OTC PINK:GTSIF) (CSE:LOBE). Lobe Sciences is a life sciences company focused on psychedelic medicines. To view the new research report, along with disclosures and disclaimers, or to download it in its entirety, please visit https:bit.ly3dIWXKe

Lobe Sciences is a life sciences company focused on psychedelic medicines and drug delivery to treat unmet needs representing multi-billion-dollar markets. The Company, through collaborations with industry leading partners, is engaged in drug research and development using psychedelic compounds and the development of innovative devices and delivery mechanisms to improve mental health and wellness.

Keep reading... Show less
  • Regulatory approval received in Canada.
  • Bio-fungicide product for powdery mildew suppression treatment on cannabis and hemp.
  • Product is licensed exclusively from leading multinational biological company.

 MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce receipt of regulatory approval for a powdery mildew bio-fungicide product for use on cannabis and hemp crops (the “Product”) through Canada’s Pest Management Regulatory Agency (PMRA).

Keep reading... Show less

 CanBud Distribution Corporation (CSE: CBDX) (FSE: CD0) (“CanBud” or the “Corporation”) is pleased to announce that it has closed the first tranche of its previously announced non-brokered private placement for gross proceeds of approximately $2,639,080 (the “Offering”). The second and final tranche of the Offering is expected to close on March 2, 2021.

The Corporation issued 21,992,333 Units at price of $0.12 per Unit, with each Unit comprised of one common share in the capital of the Corporation (each a “Common Share“) and one common share purchase warrant (each a “Warrant“). Each Warrant entitles the holder to purchase one additional Common Share at an exercise price of $0.22 within 24 months of the closing of the Offering (the “Warrant Term“), provided, however that if the closing price of the Common Shares on the Canadian Securities Exchange (the “CSE“) (or any such other stock exchange in Canada as the Common Shares may trade at the applicable time) is $0.25 or greater per Common Share for a period of five (5) consecutive trading days at any time after the closing date of the Offering, the Corporation may accelerate the Warrant Term such that the Warrants shall expire on the date which is 30 days following the date a press release is issued by the Corporation announcing the reduced warrant terms.

Keep reading... Show less